呼吸器感染症に対するニューキノロン系合成抗菌薬balofloxacinの臨床効果の検討

• 石岡 伸一

  広島大学医学部第二内科

• 山木戸 道郎

  広島大学医学部第二内科

書誌事項

タイトル別名

• Studies on the clinical effects of a new quinolone synthetic antimicrobial drug, balofloxacin, on respiratory infectious diseases

抄録

The clinical usefulness of a new quinolone synthetic antimicrobial drug, balofloxacin (BLFX), for respiratory infectious diseases was investigated. BLFX was administered at a dose of 100 or 200 mg twice to three times a day for 7-14 days to 1 patient with bronchiectasis with infection and 3 with infection secondary to chronic respiratory diseases. Clinical efficacy was rated effective in 3 and slightly effective in 2. Haemophilus influenzae and Haemophilus parainfluenzae were isolated as the pyogenic bacteria from 2 patients. H. parainfluenzae was eradicated, but H. influenzae persisted. No side effects or abnormal changes in clinical laboratory test values probably attributable to the drug were observed in any of the patients.

収録刊行物

• 日本化学療法学会雑誌

  日本化学療法学会雑誌 43 (Supplement5), 553-555, 1995

  公益社団法人 日本化学療法学会

キーワード

• 呼吸器感染症

詳細情報

• CRID: 1390001206288633728
• NII論文ID: 10005469130
• NII論文ID: 130004297502
• NII書誌ID: AN10472127
• DOI: 10.11250/chemotherapy1995.43.supplement5_553
• ISSN: 18845886
• ISSN: 13407007
• Web Site: https://search.jamas.or.jp/link/ui/1996086774
• 本文言語コード: ja
• データソース種別:
  • JaLC
  • CiNii Articles
• 抄録ライセンスフラグ: 使用不可